RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:MBC phase 3Remember that Accelerated Approval provides that pelareorep can be approved in HR+/HER2- while the Phase 3 is running so ONCY should be going after this developing option during its iterative meetings with the FDA.